Visionary has partnered with Canada BRAUN Bio Technology Group Inc. to establish Visionary Biotech Group Inc in Toronto. Visionary possesses world-class biochip technology products, filling a gap in Canada’s market. BRAUN founded in March 2011 at the University of British Columbia in Vancouver, Canada, by Canadian academicians including Victor C.M. Leung from the Royal Society of Canada and the Canadian Academy of Engineering, along with American academicians. With an accumulated investment of nearly US$150 million over more than a decade, BRAUN has focused on developing biochips, collaborating with renowned medical institutions in the United States and Canada to develop multiple products used in medical bed testing, drug development, animal quarantine, and cold chain transportation. These products include medical chips, animal chips, cold chain chips, and agricultural chips, among others. Currently, the products have completed clinical testing, process validation, and small-scale production. Visionary has partnered with Zhejiang Ruikun Technology Group in China to invest US$300 million in building a factory in Nantong, China, filling a gap in China’s market. The factory is scheduled to commence production in March 2025, with a projected output value of over US$3 billion in the next five years, creating significant economic and social value for Visionary.